STOCK TITAN

RxSight CFO sells 7,765 shares after RSU vest

RxSight’s CFO had RSUs vest into common stock and sold a portion of shares solely to cover related tax withholding obligations.

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

RxSight, Inc. (RXST) reported that Chief Financial Officer Mark Wilterding had Restricted Stock Units vest and related share movements in late August 2026. On August 31, 2026, 20,441 RSUs, each representing a contingent right to one share of common stock, converted into 20,441 common shares, leaving him with 122,646 shares held directly after this derivative transaction. On September 2, 2026, he sold 7,765 common shares at $6.96 per share to cover tax withholding obligations arising from the RSU vesting, which the company states did not represent a discretionary sale. No Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider Wilterding Mark
Role Chief Financial Officer
Sold 7,765 shs ($54K)
Approx. gross sale proceeds $54K
Type Security Shares Price Value
Sale Common Stock F2 7,765 $6.96 $54K
Exercise Restricted Stock Unit F1, F3 20,441 $0.00 $0.00
Exercise Common Stock F1 20,441 -- --
Holdings After Transaction: Restricted Stock Unit — 122,646 contracts (Direct); Common Stock — 25,049 shares (Direct)
Footnotes (3)
  1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  2. F2. Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.
  3. F3. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award vested on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period.
Shares sold 7,765 shares Common stock sale on September 2, 2026 to cover tax withholding
Sale price per share $6.96 per share Price for 7,765 common shares sold on September 2, 2026
RSUs converted 20,441 units Restricted Stock Units converted into common stock on August 31, 2026
Common shares received from RSUs 20,441 shares Shares of common stock underlying vested RSUs on August 31, 2026
Holdings after RSU transaction 122,646 shares Directly held common shares after derivative transaction as of August 31, 2026
RSU vesting start fraction 1/8 of award Initial RSU vesting on February 28, 2026 under four-year schedule
Restricted Stock Unit financial
"Each restricted stock unit ("RSU") represents a contingent right to receive"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
contingent right financial
"represents a contingent right to receive one share of the Issuer's Common"
tax withholding obligations financial
"shares sold to cover the tax withholding obligations in connection with"
Service Provider financial
"Subject to the Reporting Person continuing to be a Service Provider"
Equity Incentive Plan financial
"as defined in the Issuer's 2021 Equity Incentive Plan) through each"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

FAQ

What insider transactions did RxSight (RXST) disclose for its CFO?

RxSight disclosed that CFO Mark Wilterding had 20,441 RSUs convert into common stock on August 31, 2026, and sold 7,765 shares on September 2, 2026 to cover tax withholding obligations from that vesting.

How many RxSight (RXST) shares did the CFO sell and at what price?

On September 2, 2026, CFO Mark Wilterding sold 7,765 shares of RxSight common stock at $6.96 per share. The company notes the sale was made to cover tax withholding obligations related to RSU vesting.

How many RxSight (RXST) shares did the CFO acquire through RSU vesting?

On August 31, 2026, 20,441 Restricted Stock Units held by CFO Mark Wilterding converted into 20,441 shares of RxSight common stock, reflecting the vesting of those RSUs under the company’s equity incentive plan.

What are the CFO’s reported RxSight (RXST) holdings after the RSU transaction?

After the August 31, 2026 RSU conversion, CFO Mark Wilterding is reported as holding 122,646 shares of RxSight common stock directly. This figure is stated as of that derivative transaction in the filing data.

Were the RxSight (RXST) insider transactions under a Rule 10b5-1 plan?

No. The filing indicates that no Rule 10b5-1 trading plan is reported for these transactions, and a footnote specifies the sale was to satisfy tax withholding obligations, not a discretionary sale.

What is the vesting schedule for the CFO’s RxSight (RXST) RSU award?

The RSU award vests over four years if the CFO continues as a Service Provider: one-eighth vested on February 28, 2026, and one-eighth will vest every six months thereafter on the last day of February and August during the four-year period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wilterding Mark

(Last)(First)(Middle)
100 COLUMBIA

(Street)
ALISO VIEJO CALIFORNIA 92656

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/31/2026M20,441A(1)32,814D
Common Stock09/02/2026S(2)7,765D$6.9625,049D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)08/31/2026M20,441 (3) (3)Common Stock20,441$0122,646D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
2. Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.
3. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award vested on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period.
/s/ Jim Schindler, as Attorney-in-Fact09/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)